Tagged with Cooper

Argentina Has Argentina, for years one of the economic basket cases of Latin America, finally turned a corner? And is its pharma industry set for a bounce back?   Firebrand TV pundit-turned politician Javier Milei was elected President in late 2023 on a promise to slash public spending and state intervention.…

Argentina Juan Jose Marconi, Executive Director of Cooperala, offers a unique perspective shaped by decades of leadership across Argentina’s pharmaceutical and healthcare sectors. With a strong academic background in applied mathematics, industrial engineering, and economics, Marconi has led both major pharmaceutical companies and national healthcare institutions. Since 2021, he has been…

Puerto Rico Spending almost 30 years working for a single company is almost unheard of in today’s life science industry, where executives chop and change between firms with bewildering frequency.   However, in CooperVision – one of the world’s leading soft contact lens manufacturers with Puerto Rico at its beating heart –…

Puerto Rico Rolando Torres, Chief Operations Officer for CooperVision, a division of global medical device company CooperCompanies, discussed the significant growth and investment CooperVision has experienced in Puerto Rico since 2019, including expansions in manufacturing, packaging, and a workforce increase from 1,700 to nearly 2,500 employees. He highlighted the company’s $500 million…

Saudi Arabia Saudi Arabia’s pharmaceutical sector continues its impressive growth leadership within the region. With a 9.1 percent market growth in 2024 and a projected USD 11.6 billion in sales, the Kingdom now commands nearly a third of the entire MENA pharma market. But this story goes far beyond impressive numbers. Through…

Saudi Arabia Cooper Pharma, with its 90-year legacy, is at the forefront of transforming the pharmaceutical landscape in the Middle East. From localizing production in Saudi Arabia to pioneering collaborations with global institutions, the company is driving innovation in a rapidly evolving market. As Saudi Arabia’s Vision 2030 reshapes the future of…

Middle East & Africa Roula Youssef Halabi, SVP Global Fertility Services, discusses her six-year journey at CooperSurgical, establishing a footprint in the Middle East, overcoming cultural biases as a female executive and the shift that has led GCC countries to increasingly recognize the importance of women’s health. She also speaks about the need for…

Morocco Cooper Pharma is one of Morocco’s leading domestic pharmaceutical manufacturers and has expanded its presence across Europe, the Middle East, and Africa in recent years. CEO Ayman Cheikh Lahlou emphasizes the importance of healthcare investment for a developing nation, highlighting Morocco’s commitment to self-sufficiency in pharmaceuticals, the potential for Morocco…

Morocco Morocco, one of the most significant pharmaceutical markets in Africa, boasts a number of domestic firms. Here we highlight eight of the most significant of these companies, the scope of their operation in Morocco and beyond Africa, and the partnerships they have struck with multinational firms.   Galenica    …

Puerto Rico “Medical device manufacturing has a long history on the island, starting with Baxter in the 1950s. Today, 30 world-leading medical device companies are present in Puerto Rico generating 20,000 direct jobs across 70 manufacturing plants producing more than 2,500 different types of devices, including many critically important life-sustaining products such…

Puerto Rico Rolando Torres, executive vice president of global manufacturing for CooperVision, explains why Puerto Rico is a force to be reckoned with in medical device and pharmaceutical manufacturing. Moreover, he provides a general overview of their manufacturing operations and their large-scale efforts to make sustainable practices the new global standard.  …

Korea Jong-Gu Chung, general manager of CooperVision Korea, lifts the lid on his strategy to establish their position in the Korean market for contact lenses. Chung also gives his assessment of the impact price-driven competition for lenses is having on the market, both for providers and users, and offers his ambition…